Total Payments
$6,295
2024 Payments
$805.11
Companies
29
Transactions
341
Medicare Patients
992
Medicare Billing
$169,289
Payment Breakdown by Category
Food & Beverage$6,167 (98.0%)
Education$97.75 (1.6%)
Research$30.60 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,167 | 329 | 98.0% |
| Education | $97.75 | 11 | 1.6% |
| Unspecified | $30.60 | 1 | 0.5% |
Payments by Type
General
$6,265
340 transactions
Research
$30.60
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,846 | 113 | $0 (2024) |
| ABBVIE INC. | $1,618 | 71 | $0 (2024) |
| PFIZER INC. | $600.30 | 43 | $0 (2024) |
| Genentech USA, Inc. | $414.44 | 27 | $0 (2024) |
| GENZYME CORPORATION | $304.13 | 9 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $240.54 | 11 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $205.24 | 17 | $0 (2019) |
| Celgene Corporation | $203.88 | 11 | $0 (2019) |
| Janssen Biotech, Inc. | $116.29 | 4 | $0 (2024) |
| Smith+Nephew, Inc. | $94.62 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $805.11 | 29 | ABBVIE INC. ($276.51) |
| 2023 | $513.38 | 25 | ABBVIE INC. ($245.74) |
| 2022 | $143.24 | 4 | Smith+Nephew, Inc. ($94.62) |
| 2021 | $630.97 | 42 | Amgen Inc. ($344.73) |
| 2020 | $589.72 | 34 | Amgen Inc. ($250.55) |
| 2019 | $1,080 | 64 | AbbVie, Inc. ($415.97) |
| 2018 | $1,286 | 73 | Amgen Inc. ($412.96) |
| 2017 | $1,247 | 70 | Genentech USA, Inc. ($277.21) |
All Payment Transactions
341 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: IMMUNOLOGY | ||||||
| 10/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Inflammation | ||||||
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: IMMUNOLOGY | ||||||
| 09/20/2024 | Organogenesis Inc. | AFFINITY (Medical Supply) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: WOUND CARE | ||||||
| 09/13/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.37 | General |
| Category: IMMUNOLOGY | ||||||
| 09/05/2024 | Genentech USA, Inc. | Actemra (Biological) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: Immunology | ||||||
| 08/29/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.45 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: Inflammation | ||||||
| 07/19/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $14.20 | General |
| 06/28/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Inflammation | ||||||
| 06/21/2024 | GENZYME CORPORATION | KEVZARA (Biological) | Food and Beverage | In-kind items and services | $35.04 | General |
| Category: Rheumatology | ||||||
| 06/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Inflammation/Rare Disease | ||||||
| 06/07/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $25.37 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/24/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Inflammation | ||||||
| 05/11/2024 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $49.49 | General |
| Category: Immunology | ||||||
| 05/10/2024 | Janssen Biotech, Inc. | SIMPONI ARIA (Biological), TREMFYA | Food and Beverage | In-kind items and services | $59.52 | General |
| Category: Immunology | ||||||
| 05/09/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $127.98 | General |
| Category: IMMUNOLOGY | ||||||
| 05/04/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Immunology | ||||||
| 04/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2024 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: Inflammation | ||||||
| 03/22/2024 | AstraZeneca Pharmaceuticals LP | SAPHNELO (Biological) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Inflammation and Autoimmunity | ||||||
| 03/16/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/08/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3, DOUBLE-BLIND, MULTICENTER STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF BARICITINIB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) | Eli Lilly and Company | $30.60 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 199 | 416 | $51,655 | $33,557 |
| 2022 | 4 | 220 | 449 | $58,701 | $39,610 |
| 2021 | 4 | 261 | 577 | $75,448 | $50,644 |
| 2020 | 5 | 312 | 594 | $76,752 | $45,478 |
Total Patients
992
Total Services
2,036
Medicare Billing
$169,289
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 325 | $43,875 | $29,029 | 66.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $4,992 | $2,692 | 53.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 26 | 32 | $2,464 | $1,596 | 64.8% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 28 | 35 | $323.75 | $241.06 | 74.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 148 | 373 | $50,355 | $34,775 | 69.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $6,864 | $3,875 | 56.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 14 | 16 | $1,232 | $784.49 | 63.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 25 | 27 | $249.75 | $175.52 | 70.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 169 | 477 | $64,360 | $43,709 | 67.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $9,360 | $5,776 | 61.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 15 | 18 | $1,386 | $891.14 | 64.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 32 | 37 | $342.25 | $267.58 | 78.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 190 | 463 | $62,505 | $36,733 | 58.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 54 | 54 | $11,232 | $6,709 | 59.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 17 | 19 | $1,463 | $964.52 | 65.9% |
| 20552 | Injections of trigger points in 1 or 2 muscles | Office | 2020 | 17 | 17 | $1,173 | $770.08 | 65.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2020 | 34 | 41 | $379.25 | $301.45 | 79.5% |
About Edgard Janer, M.D., P.A
Edgard Janer, M.D., P.A is a Specialist healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154353555.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Edgard Janer, M.D., P.A has received a total of $6,295 in payments from pharmaceutical and medical device companies, with $805.11 received in 2024. These payments were reported across 341 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($6,167).
As a Medicare-enrolled provider, Janer has provided services to 992 Medicare beneficiaries, totaling 2,036 services with total Medicare billing of $169,289. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Tampa, FL
- Active Since 07/07/2006
- Last Updated 02/06/2014
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1154353555
Products in Payments
- Enbrel (Biological) $1,144
- Humira (Biological) $683.07
- XELJANZ (Drug) $532.36
- RINVOQ (Biological) $519.21
- KEVZARA (Drug) $269.09
- Actemra (Biological) $220.74
- COSENTYX (Biological) $205.24
- EVENITY (Biological) $197.73
- Rituxan (Biological) $193.70
- HUMIRA (Biological) $157.66
- ORENCIA (Biological) $141.18
- Prolia (Biological) $131.85
- Rinvoq (Biological) $107.02
- KRYSTEXXA (Biological) $85.23
- RINVOQ (Drug) $84.77
- Tymlos (Biological) $78.62
- SKYRIZI (Biological) $66.09
- LYRICA (Drug) $61.74
- Cimzia (Drug) $61.53
- SIMPONI ARIA (Biological) $59.52
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Tampa
Dr. Elliot Cazes, M.d, M.D
Specialist — Payments: $753,247
Specialist $753,247
Dr. George Letson, M.d, M.D
Specialist — Payments: $444,034
Specialist $444,034
Dr. Matthew Berlet, M.d, M.D
Specialist — Payments: $137,367
Specialist $137,367
Jose Ferreira, Md, MD
Specialist — Payments: $132,962
Specialist $132,962
Dr. Nirav Patel, M.d, M.D
Specialist — Payments: $104,346
Specialist $104,346
Dr. Ricardo Costa, Md, MD
Specialist — Payments: $83,311
Specialist $83,311